ZyVersa Therapeutics' CEO, Stephen C. Glover, to Participate in the 2024 BIO International Convention
May 14, 2024 07:57 ET
|
ZyVersa Therapeutics
To learn more about ZyVersa's Inflammasome ASC Inhibitor and Renal Pipelines, schedule a one-on-one meeting on 2024 BIO International Conference's Portal.
Elevar Therapeutics to Participate in ASCO 2023 and BIO 2023; New Jersey-based Company Secures State License as It Builds Toward Commercialization
June 01, 2023 08:00 ET
|
Elevar Therapeutics
FORT LEE, N.J., June 01, 2023 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating...
Oncotelic Participating at 2023 BIO International Convention
May 16, 2023 08:00 ET
|
Oncotelic Therapeutics, Inc.
AGOURA HILLS, Calif., May 16, 2023 (GLOBE NEWSWIRE) -- Oncotelic Inc. (“Oncotelic” or the “Company”) (OTCQB:OTLC), a pioneering developer of therapeutic interventions for rare and orphan diseases...
Oncotelic Provides Update on OT-101 at the 2022 BIO International Convention
June 15, 2022 07:00 ET
|
Oncotelic Therapeutics, Inc.
AGOURA HILLS, Calif., June 15, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) (OTCQB:OTLC), developer of treatments for rare and orphan indications, including...
Qualigen Therapeutics to Present at BIO International Convention
June 14, 2022 09:00 ET
|
Qualigen Therapeutics, Inc.
CARLSBAD, Calif., June 14, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers...
Oncotelic Announces Pipeline Presentation and IPO Update of Sapu Therapeutics at the 2022 BIO International Convention
May 18, 2022 08:00 ET
|
Oncotelic Therapeutics, Inc.
AGOURA HILLS, Calif., May 18, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) (OTCQB:OTLC), developer of treatments for rare and orphan indications, including...
Syneos Health Consulting Releases 11th Annual Survey of Biopharmaceutical Dealmakers
June 05, 2019 12:15 ET
|
Syneos Health, Inc.
PHILADELPHIA, June 05, 2019 (GLOBE NEWSWIRE) -- The 11th annual Dealmakers’ Intentions Study from Syneos Health Consulting, an industry-leading biopharmaceutical management consulting firm,...
Syneos Health to Present Actionable Commercial Insights Designed for Biopharmaceutical Companies at BIO International Convention
June 05, 2018 08:55 ET
|
Syneos Health
RALEIGH, N.C., June 05, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and...
Top European Biotech, Pharma Executives Gathering to Discuss San Diego Strategic Business Partnerships
June 16, 2014 16:53 ET
|
European American Enterprise Council
SAN DIEGO, CA--(Marketwired - Jun 16, 2014) - Senior executives from leading European biotech and pharma companies will discuss how public and private sector organizations in San Diego can best...
Avid Bioservices to Present a Case Study on cGMP Production Scale-Up, Optimization and Transition From a Stainless Steel to a Fully Disposable Process at BIO International Convention
April 19, 2013 13:00 ET
|
Avid Bioservices
TUSTIN, CA--(Marketwired - Apr 19, 2013) - Avid Bioservices, Inc., a subsidiary of Peregrine Pharmaceuticals, Inc., today announced its upcoming participation at the Biotechnology Industry...